Brief: Prostatype Genomics Resolves Rights Issue Of SEK 27.3 Mln
April 15 (Reuters) - Prostatype Genomics AB PROGEN.ST: RESOLVES ON A RIGHTS ISSUE OF UNITS TO FUND COMPLETION OF US VALIDATION STUDY AND MEDICARE APPROVAL PROCESS AS WELL AS ONGOING COMMERCIALIZATION ACTIVITIES IN THE US AND EUROPE BOARD RESOLVES ON SEK 27.3 MILLION RIGHTS ISSUE Source text: ID:nMFNbJBrgZ Further company coverage: PROGEN.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Prostatype Genomics AB
See all newsBrief: Prostatype Genomics Resolves On Rights Issue To Raise About SEK 47.4 Mln
Brief: Prostatype Genomics Intends To Resolve On Rights Issue
Brief: Prostatype Genomics Reports H2 EBITDA Of SEK -17.8 Mln
Brief: Prostatype Genomics Signs Loan Financing Of SEK 10 Million
Brief: Prostatype Genomics Gets SEK 11.5 Mln Through Exercise Of Warrants